Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidental Detection of Maternal Neoplasia Through Non-invasive Cell-Free DNA Analysis (IDENTIFY), a Natural History Study

NCT04049604 is registered in ClinicalTrials.gov with National Human Genome Research Institute (NHGRI) as lead sponsor.

NCT NCT04049604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04049604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidental Detection of Maternal Neoplasia Through Non-invasive Cell-Free DNA Analysis (IDENTIFY), a Natural History Study
Lead sponsor
National Human Genome Research Institute (NHGRI)
Phase
Observational
Overall status
Recruiting
Start date
December 23, 2019
Completion date
April 30, 2029
Enrollment
365 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

maternal neoplasia